FDA Inspection 660118 — Sgarlato Med, LLC

Sgarlato Med, LLC — FEI 2939320

The FDA completed an inspection of Sgarlato Med, LLC on April 5, 2010 in San Jose, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 18 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 5, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Compliance: Devices
Location
San Jose, CA (United States)

Citations

IDCFRDescription
237121 CFR 820.30(a)Design control - no procedures
255721 CFR 820.30(c)Design input - documentation
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
262721 CFR 820.30(e)Design reviews performed following schedule
264821 CFR 820.30(f)Design verification procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
337121 CFR 820.198(a)(3)Processing MDRs {see also 803, 804}
341521 CFR 820.22Quality Audit/Reaudit - conducted
342621 CFR 820.50(a)(1)Documented evaluation
369621 CFR 820.100(b)Documentation
407121 CFR 820.30(i)Design changes - validation vs. verification
419121 CFR 806.10(a)(1)Report of risk to health
419221 CFR 806.10(a)(2)Report of violation of the Act (see 803.52(e)(9))
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures